Chargement en cours...
An update on the evidence base for peginterferon β1a in the treatment of relapsing–remitting multiple sclerosis
Peginterferon β1a is a modified form of interferon β1a with a polyethylene glycol (PEG) group attached to the α-amino group of the N terminus of the interferon molecule. This modification alters the pharmacokinetic and pharmacodynamic properties of interferon β1a, enabling reduced frequency of dosin...
Enregistré dans:
| Publié dans: | Ther Adv Neurol Disord |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066527/ https://ncbi.nlm.nih.gov/pubmed/27800024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616656296 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|